Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prolactin Deficiency, Isolated × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3076 Neoplasms 2449 Carcinoma, Non-Small-Cell Lung 1857 Prostatic Neoplasms 1620 Colorectal Neoplasms 1370 Lung Neoplasms 1267 Neoplasm Metastasis 926 Multiple Myeloma 922 Leukemia, Myeloid, Acute 883 Pancreatic Neoplasms 859 Ovarian Neoplasms 800 Melanoma 788 Carcinoma, Hepatocellular 734 Stomach Neoplasms 648 Recurrence 645 Squamous Cell Carcinoma of Head and Neck 642 Brain Neoplasms 628 Head and Neck Neoplasms 594 Glioblastoma 554 Lymphoma 549 Uterine Cervical Neoplasms 540 Precursor Cell Lymphoblastic Leukemia-Lymphoma 516 Triple Negative Breast Neoplasms 511 Carcinoma, Renal Cell 502 Hematologic Neoplasms 473 Endometrial Neoplasms 462 Colonic Neoplasms 456 Urinary Bladder Neoplasms 455 Lymphoma, Non-Hodgkin 441 Sarcoma 430

Interventions

Dopamine Agonists 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07045935 2025-09-23

ProBOLIC

University Hospital, Basel, Switzerland

Phase 4 Recruiting

Prolactin Deficiency, Isolated, Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡